GL1X · GenesisL1 explorer

Research workbench

P53 cancer mutant Y220C in complex with compound MB710

Analyse P53 cancer mutant Y220C in complex with compound MB710 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5O1I
Type
protein
Length
393 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53
UniProt
P04637
Ligands
9GH, ZN
Pockets
5 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACellular tumor antigen P53protein19610% helix, 33% strandP04637
BCellular tumor antigen P53protein1978% helix, 33% strandP04637

Ligands and binding sites

  • 9GH · 2-(diethylamino)-6-iodanyl-5-oxidanyl-7-pyrrol-1-yl-1, 3-benzothiazole-4-carboxylic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13390.610.7842EDO
21530.530.8031empty
3910.490.82209GH
41270.410.7519empty
5960.370.7519empty

Interfaces

1 interface between chains.

  • A–B · 281 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 5O1I · p53 cancer mutant Y220C in complex with compound MB710 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.